These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 12137810)

  • 1. Critical evaluation of hormonal therapy for carcinoma of the prostate.
    Chodak GW; Keane T; Klotz L;
    Urology; 2002 Aug; 60(2):201-8. PubMed ID: 12137810
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of neoadjuvant therapy for prostate cancer].
    Okada K; Hachiya T
    Nihon Hinyokika Gakkai Zasshi; 1997 Sep; 88(9):769-77. PubMed ID: 9364842
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant hormonal deprivation in locally advanced prostate cancer: does it make sense?
    Schulman CC; Wildschutz TP
    Acta Urol Belg; 1996 May; 64(2):57-61. PubMed ID: 8701814
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy.
    Scalliet P
    Acta Urol Belg; 1996 May; 64(2):63-4. PubMed ID: 8701815
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonal therapy for prostatic cancer--state of the art].
    Miyakita H
    Nihon Rinsho; 2005 Feb; 63(2):305-8. PubMed ID: 15714983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.
    Seidenfeld J; Samson DJ; Aronson N; Albertson PC; Bayoumi AM; Bennett C; Brown A; Garber A; Gere M; Hasselblad V; Wilt T; Ziegler K
    Evid Rep Technol Assess (Summ); 1999 May; (4):i-x, 1-246, I1-36, passim. PubMed ID: 11098244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate.
    DeWeese TL; Song DY
    Urology; 2000 Feb; 55(2):169-74. PubMed ID: 10688072
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of progressive, locally advanced prostate carcinoma].
    Niesel T; Breul J; Hartung R
    Urologe A; 1998 Mar; 37(2):145-8. PubMed ID: 9563123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
    Messing EM
    J Urol; 2003 Nov; 170(5):1955; author reply 1955-6. PubMed ID: 14532828
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer.
    Siddiqui SA; Boorjian SA; Blute ML; Rangel LJ; Bergstralh EJ; Karnes RJ; Frank I
    BJU Int; 2011 Feb; 107(3):383-8. PubMed ID: 21265985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.
    Seidenfeld J; Samson DJ; Hasselblad V; Aronson N; Albertsen PC; Bennett CL; Wilt TJ
    Ann Intern Med; 2000 Apr; 132(7):566-77. PubMed ID: 10744594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of prostate cancer].
    Imre R
    Orv Hetil; 2005 Aug; 146(35):1839-42. PubMed ID: 16187544
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of advanced prostate cancer].
    Leisinger HJ; Jichlinski P
    Rev Med Suisse Romande; 1999 Jun; 119(6):507-11. PubMed ID: 10422478
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal therapy in the management of prostate cancer: from Huggins to the present.
    Garnick MB
    Urology; 1997 Mar; 49(3A Suppl):5-15. PubMed ID: 9123737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prostate cancer conundrum.
    Albertsen PC
    J Natl Cancer Inst; 2003 Jul; 95(13):930-1. PubMed ID: 12837821
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer.
    Hellerstedt B
    Urology; 2003 Dec; 62 Suppl 1():79-86. PubMed ID: 14747045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal management of advanced adenocarcinoma of the prostate.
    Miles BJ
    Henry Ford Hosp Med J; 1989; 37(1):16-8. PubMed ID: 2670839
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of prostate cancer].
    Romics I
    Orv Hetil; 2010 Apr; 151(14):580-3. PubMed ID: 20332076
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer--treatment of disseminated disease.
    Abi-Aad AS; Opsomer RJ
    Acta Urol Belg; 1996 May; 64(2):67-76. PubMed ID: 8701817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.